A randomized double-blind placebo-controlled study to assess the safety in a one-year of orally administered microencapsulated ragweed pollen extract.

Trial Profile

A randomized double-blind placebo-controlled study to assess the safety in a one-year of orally administered microencapsulated ragweed pollen extract.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 31 Oct 2011

At a glance

  • Drugs Ragweed allergy immunotherapy (Primary)
  • Indications Grass pollen hypersensitivity; Seasonal allergic rhinitis
  • Focus Adverse reactions
  • Sponsors Curalogic
  • Most Recent Events

    • 22 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top